Back to search
FDAFDA · Food and drugs·Recall number D-1522-2015

HCG 625 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compounding Pharmacy of America, Knoxville, TN

Published September 23, 2015 · Recall initiated: June 2, 2015

Summary

FDA records drug Class II recall D-1522-2015, published September 23, 2015 and initiated June 2, 2015. Recalling firm: The Compounding Pharmacy of America; Status: Terminated; Reported quantity: 1043 ml total; Lot: All lots distributed between November 2014 and May 2015; 05072015@2, 7/6/2015; 04082015@25, 6/7/2015; 03042015@54, 6/2/2015; 04142015@16, 6/13/2015; 03312015@37, 5/30/2015; 04062015@75, 6/5/2015; 05112015@15, 7/10/2015; 04272015@21, 6/26/2015; 04272015@62, 6/26/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
The Compounding Pharmacy of America
Distributor
Nationwide
Lot
All lots distributed between November 2014 and May 2015; 05072015@2, 7/6/2015; 04082015@25, 6/7/2015; 03042015@54, 6/2/2015; 04142015@16, 6/13/2015; 03312015@37, 5/30/2015; 04062015@75, 6/5/2015; 05112015@15, 7/10/2015; 04272015@21, 6/26/2015; 04272015@62, 6/26/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was HCG 625 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compounding Pharmacy of America, Knoxville, TN recalled?

Yes. FDA published recall D-1522-2015 on September 23, 2015. Reported hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What should I do if I have this product?

Voluntary: Firm initiated · Telephone